Metavista3D Inc. (TSXV: DDD) (FSE: E3T) ("Metavista3D" or the "Company") is pleased to announce that it has closed its ...
Akari Therapeutics Plc (Nasdaq: AKTX), a biotechnology company developing next-generation precision bi-functional antibody ...
In the Soundtrack of Our Lives, one of the songs that I still get to hear from time to time on Sirius XM, is “Still the One” ...
ThreeD Capital Inc. ("ThreeD” or the "Company”) (CSE:IDK / OTCQX:IDKFF) a Canadian-based venture capital firm focused on opportunistic investments in companies in the junior resources and disruptive ...
Tenax Therapeutics, Inc. (Nasdaq: TENX) (the "Company” or "Tenax Therapeutics”), a Phase 3, development-stage pharmaceutical company using clinical insights to develop novel cardiopulmonary therapies, ...
Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the “Company” or “Organigram”), a leading licensed producer of cannabis, announced today that on F ...
Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) today announced it has arranged a non-brokered private placement offering ...
FOBI AI Inc. (FOBI:TSXV) (FOBIF:OTCQB) (“Fobi” or the “Company”) announces that, further to its news releases dated December 24, 2025, and February ...
Our Investment Funds Team reviews changes to two fees from the Financial Industry Regulatory Authority (FINRA) that begin July 1, 2025.
CALGARY, AB / ACCESS Newswire / March 5, 2025 / Carbeeza Inc. ("Carbeeza" or the "Company") (TSXV:AUTO)(OTCQB:CRBAF) is pleased to announce that it has closed its previously announced non-brokered pri ...
Spartan Capital Securities, LLC acted as the sole placement agent in this private offering. The proceeds from this offering will further Lipella’s mission to develop innovative therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results